For about a decade, aesthetic medicine seemed to push surgery into the background: botulinum toxin and hyaluronic acid were supposed to be enough. The 2026 figures tell a different story. Patients are returning to the operating room, and this shift can be seen both in Germany and worldwide.

Germany: facelifts rise, and so does the average age

According to the 2026 statistics of the DGÄPC (the German society of aesthetic plastic surgery), upper blepharoplasty is the leading procedure (11.7%), ahead of botulinum toxin (11.3%). Facial lifts (face, neck, forehead, brows) together reach 12.6% of procedures, a clear increase. The average patient age rises to 44.9, a record.

Another lesson: among the youngest patients, it is not social-media trends that dominate, but breast surgery (augmentation, reduction, lift), which accounts for almost one procedure in two.

45-year-old woman with a naturally rejuvenated face
Illustration — after 40, recovering a rested, natural face through structural surgery.

Worldwide: 'filler fatigue'

The ISAPS 2025 global survey confirms the trend. Hyaluronic acid injections dropped by about 25%, while the breast lift (mastopexy) jumped by 48% — the largest rise of the year — and breast augmentation fell slightly (−2.2%). Blepharoplasty became the n°1 procedure for both women and men (I devoted a dedicated article to it).

Professionals speak of 'filler fatigue': weariness with repeated, sometimes accumulated injections that end up weighing the face down without correcting the cause of ageing. There is a shift towards autologous fat, collagen biostimulators and, above all, structural surgery.

Why injectables hit a ceiling

Injections have their place: they are excellent for targeted corrections, maintenance, or younger patients. But they have a physical limit:

  • they add volume, whereas after 40-45 the main problem is often laxity of the tissues and ligaments;
  • filling a face that is descending ends up widening and freezing it, without lifting it;
  • their cumulative cost over several years can exceed that of surgery, for a less lasting result.

What a real facelift achieves

A modern facelift, particularly a deep plane facelift, repositions tissues and ligaments instead of filling them. The result is a rested, natural and lasting face — with no 'pulled' or 'puffy' look. It can be complemented by fat grafting or blepharoplasty, followed by light injectable maintenance, this time in small doses.

The point is not to pit surgery against aesthetic medicine, but to use each tool at the right time. After 40, when injectable maintenance is no longer enough, the question deserves an honest discussion in consultation. You can learn more about the facelift and the breast lift.

Injections maintain a face; surgery corrects its architecture. Knowing when to move from one to the other is the whole art of good advice.

Sources: DGÄPC — DGÄPC-Statistik 2026: Trends & Zahlen der Ästhetischen Chirurgie; International Society of Aesthetic Plastic Surgery (ISAPS) — Global Survey 2025.

Medical disclaimer: this article is for information only and does not replace a medical consultation. The choice between injectable treatment and surgery depends on an individual clinical assessment. Results vary from one person to another.